Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
News about Option Care Health, Inc. (OPCH) centers on its role as the nation’s largest independent provider of home and alternate site infusion services and on its regular financial and corporate updates. The company issues detailed quarterly earnings releases, often accompanied by Form 8-K filings, that cover net revenue, net income, earnings per share, and non-GAAP metrics such as Adjusted EBITDA, Adjusted net income and Adjusted diluted EPS.
Investors following OPCH news will see announcements of preliminary and final quarterly and full-year financial results, as well as updated financial guidance ranges for net revenue, Adjusted EBITDA and Adjusted diluted earnings per share. These releases typically include management commentary on performance, cash flow from operations, stock repurchase activity and capital structure developments.
Option Care Health also uses news releases to communicate capital allocation decisions, such as expansions of its share repurchase program authorization, and to describe amendments to its credit agreements that affect term loans and revolving credit facilities. SEC Form 8-K filings referenced in the news provide additional detail on these material definitive agreements and financial obligations.
Corporate governance and leadership changes are another recurring news theme. For example, the company has announced a Chief Financial Officer transition, outlining the incoming CFO’s background, compensation arrangements and the outgoing CFO’s advisory role. News items also highlight Option Care Health’s participation in major healthcare and finance conferences, including events hosted by J.P. Morgan, UBS, Jefferies, Deutsche Bank and Bank of America, with webcasts and presentation materials made available to investors.
In addition, Option Care Health appears in partner company releases, such as Quince Therapeutics’ announcements of a strategic relationship for specialty infusion therapy support. These items describe how Option Care Health’s national network of specialty pharmacies and ambulatory infusion suites may be used to administer specific infused therapies, particularly in rare disease indications. For ongoing coverage of these financial, strategic and operational developments, OPCH news on this page aggregates company press releases, partner announcements and related disclosures.
Option Care Health (OPCH), the largest independent provider of home and alternate site infusion services in the US, announces participation in three upcoming investor conferences in November and December 2024. The company will attend the Jefferies London Healthcare Conference on November 19 with a fireside chat at 8:30am GMT, the Bank of America Leveraged Finance Conference in Boca Raton on December 3 with a presentation at 8:50am ET, and the virtual Bank of America Home Care Conference on December 9 with a fireside chat at 11:10am ET.
Webcasts and presentation materials will be accessible at investors.optioncarehealth.com. The company operates nationwide with over 7,500 team members, including 4,500+ clinicians, serving patients with acute and chronic conditions.
Option Care Health (OPCH) reported Q3 2024 financial results with net revenue of $1,278.5 million, up 17.0% year-over-year. However, gross profit margin decreased to 20.1% from 23.3% in Q3 2023. Net income declined 4.3% to $53.9 million. The company faced supply chain disruptions due to Hurricane Helene affecting IV solution bags availability. Updated 2024 guidance projects net revenue of $4.9-4.95 billion and Adjusted EBITDA of $438-443 million. Cash flow from operations significantly improved to $160.4 million compared to $61.0 million in Q3 2023.
Option Care Health Inc. (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the US, has announced it will release its third quarter 2024 financial results on Wednesday, October 30, 2024, before the market opens. The company will host a conference call at 8:30 a.m. E.T. on the same day to review the results.
Participants can pre-register for the conference call using the provided link. Additionally, a live audio webcast will be available on the company's investor relations website. A replay of the call will be accessible via webcast for on-demand listening shortly after the call's completion and will remain available for approximately 90 days.
Option Care Health (Nasdaq: OPCH) reported its Q2 2024 financial results, showing mixed performance. Net revenue increased 14.8% to $1,227.2 million, but gross profit decreased 0.6% to $249.4 million. Net income fell 53.6% to $53.0 million, or $0.30 per diluted share. Adjusted EBITDA slightly decreased by 1.5% to $108.4 million.
The company updated its full-year 2024 guidance, expecting net revenue between $4.75 billion and $4.85 billion, and Adjusted EBITDA of $435 million to $450 million. Option Care Health maintains its projection for cash flow from operations of at least $300 million.
Notable actions include repurchasing approximately $78.1 million of stock and amending the First Lien Credit Agreement to reduce interest rates and increase liquidity by $50.0 million.
Option Care Health (NASDAQ: OPCH), a leading provider of home and alternate site infusion services, will announce its second quarter 2024 financial results on July 31, 2024, before the market opens. The company will also hold a conference call at 8:30 a.m. E.T. on the same day to discuss the results.
Participants can pre-register for the call through a designated link, and a live audio webcast will be available online. A replay of the call will be accessible for 90 days after the event.
Option Care Health, the largest independent national provider of home and alternate site infusion services, announced its participation in three upcoming investor conferences. These include the William Blair 44th Annual Growth Stock Conference in Chicago on June 4, 2024, the Jefferies Global Healthcare Conference in New York on June 5, 2024, and the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 11, 2024. Presentations and fireside chats will be held at each event, and webcast links along with related materials will be available on the company's investor relations website.
Option Care Health Inc. will participate in the BofA Securities Health Care Conference in Las Vegas on May 14, 2024, with a fireside chat presentation. The company is the largest independent national provider of home and alternate site infusion services.
Summary not available.
Summary not available.
Summary not available.